Pharmafile Logo

VBH

- PMLiVE

Patient outcomes in practice: delivering value that transforms lives

Over the next five years, the NHS needs to drive efficiencies of £22bn. Like all global healthcare systems, it faces the challenge of improving the health of larger and older...

The true potential of mobile health tech

Are patients willing to adopt digital?

Novartis changes executive committee

Robert Welteverden is appointed head of Novartis Business Services

- PMLiVE

It’s all about patient outcomes… right?

Lessons from history: a design thinking perspective

Global mHealth market predicted to reach $58.8bn by 2020

And digital therapeutics could rival mainstream pharmaceutical products, according to a report

Improving NHS sustainability through service redesign partnerships and effective communications

With year-on-year increases in demand and the imperative to reduce its deficits, the NHS must look beyond merely doing more of the same if it is to become sustainable. Never...

NHS collaborates with VisualDX

CCGs will now have access to diagnostic clinical decision support resource

- PMLiVE

Real-world data finds patients feel better on Entresto, says Novartis

Patients on Entresto reported an “early, statistically significant improvement in health status”

- PMLiVE

The call for a more strategic medical affairs community

How its leaders are stepping up to the plate

Building trust in our industry

For the last 18 years the Edelman Trust Barometer has tracked levels of trust across the world in the four institutions of business, government, media and NGOs. During that time...

- PMLiVE

Digital skills gap hinders UK healthcare innovation

Report calls for greater emphasis on HCPs’ digital and data literacy education

- PMLiVE

Novartis, Amgen set low price for first CGRP migraine drug

Aimovig has a list price of $6,900 per year

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links